Manimaran, D.; Elangovan, N.; Palanisamy, V. Anti-Tumorgenic Impact of Nano-Formulated Peptide HIF-Alpha Therapy by DMBA Induced Mammary Carcinoma in Rodent Type. Jordan j. pharm. sci. 2024, 17, 783-793.